Upcoming Webinars

How Early Protocol Design Shapes Supply Strategy and RTSM Readiness

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Pharma, Pharma Manufacturing & Supply Chain,
  • February 11, 2026 | 1pm EST (12pm CST / 10am PST / 6pm GMT)
  • 60 min

Upcoming Webinars

Transforming Pediatric Rare Disease Trials Through Modeling and Simulation, and Site Networks

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Pharma,
  • February 18, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

Accelerating Clinical Entry for Poorly Soluble Molecules: A Proven and Structured Roadmap

Biotech, Drug Discovery & Development, Life Science, Pharma, Preclinical,
  • February 19, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

How Community-Based Trials Are Delivering Results: Investigator and Site Perspectives

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Patient Recruitment & Retention, Pharma,
  • February 19, 2026 | 12pm EST (11am CST / 9am PST / 5pm GMT)
  • 60 min

Upcoming Webinars

Site Selection Solutions Using Patient Insights for Rare Disease Trials

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Patient Recruitment & Retention, Pharma,
  • February 20, 2026 | 10am EST (NA) / 3pm GMT (UK) / 4pm CET (EU-Central)
  • 60 min

Upcoming Webinars

February 11, 2026

How Early Protocol Design Shapes Supply Strategy and RTSM Readiness
February 18, 2026

Transforming Pediatric Rare Disease Trials Through Modeling and Simulation, and Site Networks
February 19, 2026

Accelerating Clinical Entry for Poorly Soluble Molecules: A Proven and Structured Roadmap
February 19, 2026

How Community-Based Trials Are Delivering Results: Investigator and Site Perspectives
EmVenio Hero
February 20, 2026

Site Selection Solutions Using Patient Insights for Rare Disease Trials
February 24, 2026

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 1)
February 24, 2026

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 2)
February 24, 2026

Addressing Rising LQPPV and Lifecycle Management Demands Using Applied AI
Hero-Banner-1600
February 24, 2026

How Moderna Uses Decision Intelligence to Enable an Autonomous Cold Chain
February 25, 2026

Maximizing Value in Early-Phase Oncology Trials: Innovative Endpoints for Early Insights
February 25, 2026

From FIH to POC — Designing Phase I/Ib Trials with Efficiency
February 26, 2026

Responsible Data Return in Rare Disease Clinical Trials: What Sponsors Need to Know
February 26, 2026

Engaging Community Voices to Improve Clinical Trial Access
February 26, 2026

How to Safely Harness R and SAS for Cutting-Edge and Validated Clinical Analytics
February 27, 2026

Peptide Synthesis: New Sustainable Strategies for Regulatory and Market Demands
February 27, 2026

3 Key Trends Transforming the Future of Rare Disease Clinical Development